Business Information
The group's principal activity is to develop, manufacture and market oral fluid specimen collection devices and diagnostic products. The group designs tests for alcohol abuse. The group's products include: the orasure(R) and intercept(R) oral fluid collection devices; the oraquick(R) rapid diagnostic test device; histofreezer(R) portable cryosurgical systems; immunoassay tests and reagents; western blot confirmatory tests for HIV and other products. The products are sold in the United States and certain foreign countries to government agencies, clinical laboratories, physician's offices, hospitals, commercial and industrial entities, and various distributors.
|
|
Name |
Title
|
Email
|
| Douglas Watson | Chmn. | N/A | | Ronald Spair | CFO, COO | N/A | | Jack Jerrett | Sr. VP - General Counsel, Sec. | N/A | | Joseph Zack | Exec. VP - Marketing, Sales | N/A | | Mark Kuna | Sr. VP - Finance, Controller | N/A |
|
|
Year |
Sales |
Net Income |
| 2006 | 68,155 | 5,268 | | 2005 | 69,366 | 27,448 | | 2004 | 54,008 | (560)
|
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
|
